Similar benefits were observed in a study combining omalizumab with milk OIT, where dose-related adverse reactions were significantly reduced during escalation, although improvements in desensitization and long-term tolerance did not reach statistical significance.
← all excerpts
Oral Immunotherapy-Induced Changes in IgE, IgG, and IgA: A Review of Antibody Isotype Shifts and Their Clinical Relevance in Food Allergy.
1
—
—